From: Causes of death after first time venous thromboembolism
Age | All cause death | Non-CV death | CV death | All cancer death | Other death | |
---|---|---|---|---|---|---|
Control | 18–49 | 0.2 (0.2–0.2) | 0.0 (0.0–0.0) | 0.2 (0.2–0.2) | 0.1 (0.1–0.1) | 0.2 (0.2–0.2) |
50–59 | 0.8 (0.8–0.9) | 0.1 (0.1–0.1) | 0.8 (0.8–0.9) | 0.4 (0.4–0.5) | 0.5 (0.5–0.6) | |
60–69 | 2.2 (2.1–2.3) | 0.3 (0.3–0.3) | 2.1 (2.0–2.1) | 1.2 (1.1–1.2) | 1.2 (1.1–1.3) | |
70–79 | 4.7 (4.6–4.8) | 0.8 (0.8–0.9) | 4.2 (4.1–4.3) | 2.2 (2.1–2.3) | 2.8 (2.6–2.9) | |
80+ | 15.5 (15.3–15.8) | 4.3 (4.2–4.5) | 11.4 (11.1–11.6) | 3.2 (3.1–3.3) | 11.3 (11.1–11.6) | |
DVT | 18–49 | 1.2 (0.8–1.6) | 0.1 (0.0-0.2) | 1.2 (0.9–1.7) | 0.8 (0.6–1.3) | 0.4 (0.2–0.9) |
50–59 | 2.7 (2.1–3.6) | 0.1 (0.0-0.3) | 2.8 (2.2–3.8) | 2.0 (1.5–2.8) | 0.9 (0.5–1.7) | |
60–69 | 5.6 (4.8–6.7) | 0.3 (0.2–0.5) | 5.8 (4.8–6.9) | 4.3 (3.6–5.3) | 1.6 (1.1–2.4) | |
70–79 | 7.4 (6.5–8.5) | 0.6 (0.4–0.9) | 7.3 (6.3–8.5) | 4.9 (4.1–5.9) | 2.9 (2.1–3.8) | |
80+ | 16.1 (14.3–18.0) | 3.1 (2.5–3.8) | 12.4 (10.8–14.2) | 4.9 (4.0–6.1) | 10.2 (8.5–12.2) | |
PE | 18–49 | 2.4 (1.7–3.3) | 0.1 (0.0-0.3) | 2.4 (1.7–3.4) | 1.5 (1.0–2.3) | 1.2 (0.6–2.2) |
50–59 | 6.7 (5.4–8.4) | 0.4 (0.2–0.8) | 6.7 (5.3–8.5) | 4.6 (3.5–6.1) | 2.4 (1.5–3.9) | |
60–69 | 9.8 (8.5–11.4) | 0.5 (0.3–0.8) | 10.0 (8.5–11.6) | 7.4 (6.2–8.8) | 2.7 (1.8–3.8) | |
70–79 | 14.2 (12.7–15.9) | 1.1 (0.8–1.5) | 13.5 (12.0–15.3) | 8.6 (7.5–9.9) | 6.1 (4.9–7.6) | |
80+ | 26.6 (24.1–29.3) | 4.2 (3.6–5.0) | 20.6 (18.3–23.1) | 8.6 (7.2–10.2) | 16.7 (14.2–19.6) |